DOCSLIB.ORG

Rectal Drug Delivery System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rectal Drug Delivery System Indo American Journal of Pharmaceutical Research, 2018 ISSN NO: 2231-6876 RECTAL DRUG DELIVERY SYSTEM Akula Prudhvi Sai Krishna, Mohammed Haneefunnisa GITAM Institute of Pharmacy, Gitam (Deemed To Be University), Rushikonda, Visakhapatnam-45. ARTICLE INFO ABSTRACT Article history Rectal biologic supply is an able alternating to articulate and parenteral avenue of Received 28/08/2018 administering in fractional abstention of aboriginal canyon metabolism and protein peptide Available online biologic delivery. This avenue allows both bounded and systemic analysis of drugs. 30/09/2018 Controlled assimilation accessory of drugs can be accomplished by the abdominal avenue because of the connected altitude in the abdominal environment. In the present analysis Keywords presents assorted dosage forms acclimated in abdominal route, factors accompanying rectal Rectal administration, avenue of assimilation, fate of biologic absorption. This analysis as well presents polymers in Factors affecting, abdominal avenue of biologic delivery. The purpose of this review was to systemize recent Applications, approaches on rectal drug delivery systems along with factors affecting the rectal absorption. Suppositories and Methods of preparation. Corresponding author Akula Prudhvi Sai Krishna Gitam Institute of Pharmacy, Gitam (Deemed To Be University), Rushikonda, Visakhapatnam-45. [email protected] Please cite this article in press as Akula Prudhvi Sai Krishna et al. Rectal Drug Delivery System. Indo American Journal of Pharmaceutical Research.2018:8(09). C opy right © 2018 This is an Open Access article distributed under the terms of the Indo American journal of Pharmaceutical 390 Research, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Page www.iajpr.com Vol 8 Issue 09, 2018. Akula Prudhvi Sai Krishnaet al. ISSN NO: 2231-6876 INTRODUCTION Rectal biologic supply systems acclimated to bear the biologic by application muco adhesive polymers is through the close film of the rectum. Abdominal biologic supply is so capital if the articulate medication is not possible, Intra venous(I.V) admission is not accessible and the patients accept adversity in swallowing, abhorrence and airsickness and for breed or children. The abdominal avenue admitting rarely the aboriginal best of biologic administering serves to articulate and invasive administration. Administration of hydrogels rectally are found to be advantageous for biologic supply [1,2]. In order to an oral indefinite quantity kind for such therapeutic agents one should defend the drug from protein degradation (in some cases) and at the same time overcome the impervious nature of the membrane barrier. The problem of protein degradation by concentrating an absorption sites is free biological process enzymes. These administration routes are nasal and body part mucous membrane. Both of those doubtless drug-absorbing areas lack massive concentrations of biological process enzymes maintain a selective barrier to the absorption of the medicine. The second drawback increasing the porousness of target mucosa has been approached by characteristic permeation enhancers or absorption adjuvant. For examples, synthetic or semi-synthetic chemical agent and gall salts. ANATOMY OF HUMAN RECTUM: The animal rectum is the terminal allotment of GastroIntestinal Tract. It is 10 – 15 cm continued hardly aggrandized allotment of the ample intestine. In the abeyant position the rectum does not accept any alive motility. Normally the rectum is abandoned & contains 2-3 ml of apathetic fungus fluid. (pH 7-8), which is buried by the beaker beef basic simple tubular glands in mucosal layer. This fungus has no enzymatic activity. There are no villi or microvilli on the abdominal film and appropriately an actual bound apparent breadth (200 – 400 cm2 ) is accessible for absorption. And this apparent breadth is acceptable to blot drugs [3,4]. DRUG ABSORPTION IN RECTUM: Fate of biologic captivated from rectum depends aloft the position of it in the rectum, both claret and aqueous argosy are affluent in the sub mucosal arena of abdominal wall. High hemorrhoidal attitude drains into the aperture circulation, so the biologic captivated in the high arena will canyon through the alarmist afore entering the systemic circulation. While the lower & average hamorrhoidal veins cesspool anon into the inferior venacava. So the drugs captivated in the lower arena of the rectum will anon access into the systemic circulation[5,6]. ADVANTAGES: Abdominal avenue offers -to-be advantages for biologic delivery. · Rapid assimilation of so abounding low atomic weight drugs, · The biologic causing astringent abhorrence & vomiting, the articulate administering may could cause emesis,in that case abdominal biologic supply arrangement is helpful, · Irritation to abdomen & baby civil associated with assertive biologic can be avoided, in that case abdominal biologic supply arrangement is helpful, · Partial artifice of aboriginal canyon metabolism, · Prevention of biologic from acerb & enzymatic abasement achieved, · Biologic assimilation can be calmly disconnected in cases of adventitious balance or suicide attempts, , in that case abdominal biologic supply arrangement is helpful, · Potential for assimilation into the aqueous system, · Retention of ample volumes, · Rate controlled biologic delivery, · Assimilation enhancement, · Target & localized biologic delivery, · Avoidance of biologic degradation, · Prolonged effect. DISADVANTAGES: · Inconvenient for patients. · The assimilation of drugs is frequently aberrant & difficult to predict. VARIOUS RECTAL DRUG DELIVERY SYSTEM: Rectal semisolids 1) Creams 2) Gels 3) Ointments 4) Suppositories 391 Page www.iajpr.com Vol 8 Issue 09, 2018. Akula Prudhvi Sai Krishnaet al. ISSN NO: 2231-6876 Rectal liquids 1) Solutions 2) Suspensions and Rectal aerosols CREAMS, GELS, OINTMENTS: These affairs are acclimated for contemporary appliance to the perianal breadth for admittance aural the anal canal. They abundantly are acclimated to amusement bounded altitude of anorectal pruritis, deepening and the affliction and ache associated with hemorrhoids. The drugs include astringents (eg. Zinc oxide), protectants and lubricants (eg. Cocoa butter, lanolin), bounded anaesthetics (eg. Pramoxine HCL), and antipruritis and anti anarchic agents (eg. Hydrocortisone). Generally the bases used in anorectal creams and ointments involves the following polyethylene glycol 300 & 3350 , chrism bases application cetyl booze & cetyl esters wax , and white petroleum and mineral oil. And the preservatives like methylparaben, propylparaben, benzlyacohol and butylated hydrocortisole (BHA) are also used. Application: Before applying abdominal ointments and chrism the perianal derma and the afflicted breadth should be bankrupt and dried. Several types of applicators are used for applications of creams. Packaging: Rectal ointments creams and gels are arranged with appropriate perforated artificial tips for articles to be administered in to the anus. RECTAL SUPPOSITORIES: Solid suppositories are the lot of accepted dosage anatomy acclimated for abdominal biologic administration. Generally these are torpedo-shaped dosage forms which alter in weight from 1 g (children) to2- 2.5 g (adult). Lipophilic drugs are usually congenital into water-soluble bases while hydrophilic drugs are formulated into the blubbery abject suppositories. Rectal suppositories fabricated from blubbery bases, melting point should activity rapidly abreast physique temperature (37°C). Ideally the resultant cook would readily breeze to activity thin, ample advantage of the abdominal tissue, in that way aspersing lag time furnishings due to apathetic absolution of the biologic from the abdominal suppository base. Water-soluble abdominal suppositories should additionally readily deliquesce at 37°C to facilitate biologic absolution and consecutive absorption. Packaging: Packaging is done afterwards lubrication with able adipose in aluminium antithesis or in added acceptable material. And with adumbration [STORE IN A COOL PLACE ] The use of gels, foams or ointments for abdominal administering can allow advantages over aqueous formulations because assimilation of the dosage anatomy in the abdominal atrium reduces accommodating acquiescence problems. Biologic absolution with semisolid dosage forms is usually bound to bounded break such as hemorrhoids and lower bowel deepening (proctitis). RECTAL LIQUIDS: Rectal suspensions, emulsions & solutions. Solutions, suspensions, or assimilation enemas represent abdominal dosage forms with actual bound application, abundantly due to aggravation of use and poor accommodating compliance. In abounding cases, these formulations are activated to administrate adverse media and imaging agents for lower GI roentgenography. Although biologic assimilation from solutions has been apparent to beat that from solid suppositories in some cases so this accurate administering avenue is alone infrequently employed. This dosage forms are mainly acclimated as enemas Assimilation bang : For systemic or bounded aftereffect this is used. Example hydrocortisone or aminophylline. Evacuation enema: For cleansing of bowel this enemas are used. For example sodium phosphate and sodium biphosphate, glycerin and doccusate potassium and ablaze mineral oil. Applicators or inserts for abdominal liquids: There are several types of applicators accessible as follow- Bubble insert, clasp insert, Rectal
Load more

Recommended publications
  • Legal Rights of Children with Epilepsy in School and Child Care – an Advocate’S Manual
    Legal Rights of Children with Epilepsy in School & Child Care AN ADVOCATE’S MANUAL AN ADVOCATE’S AN ADVOCATE’S MANUAL AN ADVOCATE’S First Edition Legal Rights of Children with Epilepsy in School and Child Care – An Advocate’s Manual First Edition Prepared by Leslie Seid Margolis Managing Attorney Maryland Disability Law Center Edited by Gary Gross Director Jeanne A. Carpenter Epilepsy Legal Defense Fund Epilepsy Foundation of America® User is hereby granted permission to copy or disseminate this publication, either in print or electronic format, provided such copies are not made, distributed or used for commercial purposes, and that the user affixes the Epilepsy Foundation’s copyright notice, and states that copying is by permission of the Epilepsy Foundation. To disseminate otherwise, or to republish, requires written permission from the Epilepsy Foundation. Permission can be obtained by contacting the Foundation’s Legal Department at 301-459-3700. The Epilepsy Foundation does not evaluate, promote or endorse commercial products, and nothing contained in this document is intended to be an endorsement of any particular treatment for seizures or epilepsy. © 2008 Epilepsy Foundation of America, Inc. Epilepsy Foundation® and Epilepsy Foundation of America® are registered trademarks of the Epilepsy Foundation of America, Inc. TABLE OF CONTENTS ACKNOWLEDGEMENTS …………………………………………….xiii ABOUT THE AUTHOR ...........................................................................xiv INTRODUCTION …………………………………………………………1 CHAPTER ONE What Do Attorneys
    [Show full text]
  • Rectal Administration of Aid-In-Dying Medications
    Rectal Administration of Aid-in-Dying Medications (NOTE: This is a medical procedure and requires a trained clinician who can evaluate the patient for this procedure, do a rectal exam to be sure that the procedure can be safely accomplished, and be responsible for potential complications. We do not recommend that this be done by families alone without significant direct clinician participation.) by Thalia DeWolf, RN, CHPN For questions and/or information, email [email protected] An Essential Warning: Aid-in-dying medications are a thick suspension of powders. They can clog a Macy Catheter. So while Macy Catheters are indeed wonderful and useful devices for end-of- life care, they should not be used for medical aid in dying. See below for proper materials. Pre-care: An intact, empty, warm, moist, well-perfused rectum assures thorough absorption of rectally administered aid-in-dying medications. Be sure your patient has good bowel care in the 72 hours before aid in dying. A daily soft BM is recommended. The best practice is to do an enema the day before or the morning of aid in dying. Within 24 hours of the procedure (or at the time of the procedure) a digital rectal exam must be performed by an experienced clinician (RN or physician) The clinician must ascertain that the lumen is patent and will accept the catheter; that the rectal vault is not filled with stool (small amounts of stool will not interfere with absorption of medications, large amounts, especially of thick, pasty stool, are likely to bind the medications and prevent absorption; that tumor has not invaded the rectum; that the rectum is warm and well-perfused).
    [Show full text]
  • Rectal Suppository & Enema Administration to Administration Unlicensed Assistive Personnel (UAP) Module/Skill Checklist
    Delegation of Medication Rectal Suppository & Enema Administration to Administration Unlicensed Assistive Personnel (UAP) Module/Skill Checklist Objective At the completion of this module, the UAP should be able to administer rectal suppository & enema medications. NOTE: 1) The RN or LPN is permitted to delegate ONLY after application of all components of the NCBON Decision Tree for Delegation to UAP and after careful consideration that delegation is appropriate: a) for this client, b) with this acuity level, c) with this individual UAP’s knowledge and experience, and d) now (or in the time period being planned). 2) Successful completion of the “Infection Control” module by the UAP should be documented prior to instruction in medication administration by this or ANY route. Procedure for: SUPPOSITORY 1. Perform skills in General Medication Administration Checklist. 2. Provide privacy. Have client void before procedure. 3. Put on clean gloves. 4. Position the client on their left (preferred) side with the top leg bent slightly. 5. Remove the foil or wrapper from the suppository, if present. 6. Apply a small amount of lubricant to the suppository and your gloved index finger on your dominant hand – the hand holding the suppository. 7. Separate the buttocks with your gloved, non dominant hand. 8. Ask the client to breathe slowly and deeply through the mouth. 9. Place tip of suppository against anus and gently insert the suppository about 4- inches along the rectal wall. Avoid putting the suppository in stool. 10. After removing your finger, squeeze buttocks together for a few minutes to help client hold in the suppository for as long as possible.
    [Show full text]
  • Consumer Education
    CONSUMER EDUCATION Massachusetts General Laws Penalties for Possession or Possession with the Intent to Distribute • Consumers may not sell marijuana to any other individual • Marijuana is a class D controlled substance under the Massachusetts Controlled Substances Act - Mass. Gen. Laws. ch. 94C, § 31 Possession for Personal Use An adult may possess up to one ounce of marijuana; up to 5 grams of marijuana may be marijuana concentrate. Within a primary residence, an adult may possess up to 10 ounces of marijuana and any marijuana produced by marijuana plants cultivated on the premises. An adult who possesses more than one ounce of marijuana or marijuana products must secure the products with a lock. • Mass. Gen. Laws. ch. 94G, § 7 • Mass. Gen. Laws. ch. 94G § 13(b) Possession of more than one ounce of marijuana is punishable by a fine of $500 and/or imprisonment of up to 6 months. However, first offenders of the controlled substances act will be placed on probation and all official records relating to the conviction will be sealed upon successful completion of probation. Subsequent offenses may result in a fine of $2000 and/or imprisonment of up to 2 years. Individuals previously convicted of felonies under the controlled substances act who are arrested with over an ounce of marijuana may be subject to a fine of $2000 and/or up to 2 years of imprisonment. • Mass. Gen. Laws. ch. 94C, § 34 Possession with Intent to Distribute For first offenders, possessing less than 50 pounds of marijuana with the intent to manufacture, distribute, dispense or cultivate is punishable by a fine of $500-$5,000 and/or imprisonment of up to 2 years.
    [Show full text]
  • Mucosal Delivery Systems of Antihypertensive Drugs: a Practical Approach in General Practice Lukasz P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Jun; 162(2):71-78. Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice Lukasz P. Bialya,b, Cezary Wojcikc, Izabela Mlynarczuk-Bialya,b Patients who are unable to receive oral medication (p.o.) are a major problem in outpatient settings, especially in home health care systems. Mucosal administration of drugs offers an alternative to the oral route, especially when the parenteral mode cannot be used. There are three main pathways of mucosal administration: sublingual/buccal, intranasal and rectal. We discuss the possibility of mucosal delivery of antihypertensive drugs. Perindopril arginine and Amlodipine besylate are registered in the EU as orodispersible tablets for oromucosal delivery, however, they are not available in all countries. For this reason, we describe other drugs suitable for mucosal delivery: Captopril and Nitrendipine in the sublingual system and Metoprolol tartrate, Propranolol and Furosemide by the transrectal route. Based on the published data and common clinical practice we discuss the use of mucosal delivery systems of all these antihypertensive drugs with special attention to their pharmacokinetics. We illustrate this mini-review with a case report of the prolonged-term use of mucosal delivery of sublingual Captopril and Nitrendipine combined with rectal Metoprolol tartrate and Furosemide in a patient with severe hypertension unable to receive medication p.o. This is also a report on the first human use of Furosemide-containing suppositories as well as prolonged-term transmucosal administration of these four drugs, describing a practical approach leading to successful control of severe hyperten- sion with four antihypertensive drugs delivered via the mucosal route.
    [Show full text]
  • September 2017 ~ Resource #330909
    −This Clinical Resource gives subscribers additional insight related to the Recommendations published in− September 2017 ~ Resource #330909 Medications Stored in the Refrigerator (Information below comes from current U.S. and Canadian product labeling and is current as of date of publication) Proper medication storage is important to ensure medication shelf life until the manufacturer expiration date and to reduce waste. Many meds are recommended to be stored at controlled-room temperature. However, several meds require storage in the refrigerator or freezer to ensure stability. See our toolbox, Medication Storage: Maintaining the Cold Chain, for helpful storage tips and other resources. Though most meds requiring storage at temperatures colder than room temperature should be stored in the refrigerator, expect to see a few meds require storage in the freezer. Some examples of medications requiring frozen storage conditions include: anthrax immune globulin (Anthrasil [U.S. only]), carmustine wafer (Gliadel [U.S. only]), cholera (live) vaccine (Vaxchora), dinoprostone vaginal insert (Cervidil), dinoprostone vaginal suppository (Prostin E2 [U.S.]), varicella vaccine (Varivax [U.S.]; Varivax III [Canada] can be stored in the refrigerator or freezer), zoster vaccine (Zostavax [U.S.]; Zostavax II [Canada] can be stored in the refrigerator or freezer). Use the list below to help identify medications requiring refrigerator storage and become familiar with acceptable temperature excursions from recommended storage conditions. Abbreviations: RT = room temperature Abaloparatide (Tymlos [U.S.]) Aflibercept (Eylea) Amphotericin B (Abelcet, Fungizone) • Once open, may store at RT (68°F to 77°F • May store at RT (77°F [25°C]) for up to Anakinra (Kineret) [20°C to 25°C]) for up to 30 days.
    [Show full text]
  • Dosage Form Description CODE
    Dosage Form Description CODE DOSAGE_FORM DOSAGE_FORM DESCRIPTION AERO Aerosol AEPB Aerosol Powder, Breath Activated AERB Aerosol, Breath Activated AERP Aerosol, Powder AERS Aerosol, Solution AUIJ Auto-injector AJKT Auto-injector Kit BAR Bar BEAD Beads CAPS Capsule CAPA Capsule Abuse- Deterrent CPCW Capsule Chewable CPDR Capsule Delayed Release CPEP Capsule Delayed Release Particles CSDR Capsule Delayed Release Sprinkle CDPK Capsule Delayed Release Thereapy Pack C12A Capsule ER 12 Hour Abuse-Deterrent CS12 Capsule ER 12 Hour Sprinkle C2PK Capsule ER 12 Hour Therapy Pack C24A Capsule ER 24 Hour Abuse-Deterrent CS24 Capsule ER 24 Hour Sprinkle C4PK Capsule ER 24 Hour Therapy Pack CP12 Capsule Extended Release 12 Hour CP24 Capsule Extended Release 24 Hour CPEA Capsule Extended Release Abuse-Deterrent CSER Capsule Extended Release Sprinkle CEPK Capsule Extended Release Therapy Pack CPCR Capsule Extended Release* CPSP Capsule Sprinkle CPPK Capsule Therapy Pack CART Cartridge CTKT Cartridge Kit CONC Concentrate CREA Cream CRYS Crystals DEVI Device TEST Diagnostic Test DPRH Diaphragm DISK Disk ELIX Elixir EMUL Emulsion ENEM Enema EXHA Exhaler EXHL Exhaler Liquid Dosage Form Description CODE DOSAGE_FORM DOSAGE_FORM DESCRIPTION EXHP Exhaler Powder EXHS Exhaler Solution EXHU Exhaler Suspension FILM Film FLAK Flakes EXTR Fluid Extract FOAM Foam GAS Gas GEL Gel SOLG Gel Forming Solution GRAN Granules GREF Granules Effervescent GUM Gum IMPL Implant INHA Inhaler INJ Injectable INST Insert IUD Intrauterine Device JTAJ Jet-injector (Needleless) JTKT Jet-injector
    [Show full text]
  • Diazepam Rectal Gel (Diastat) Administration
    LOS ANGELES UNIFIED SCHOOL DISTRICT Student Health and Human Services Division District Nursing Services DIAZEPAM RECTAL GEL (DIASTAT) ADMINISTRATION I. GENERAL GUIDELINES A. PURPOSE 1. To control acute, repetitive or prolonged seizures. 2. To prevent status epilepticus, a life-threatening condition in which seizures are continuous. 3. To administer Diastat safely and in a timely manner. B. GENERAL INFORMATION 1. Diazepam rectal gel (Diastat) is an “emergency anti-seizure medication” approved by Food and Drug Administration (FDA). Education Code 49414.7 allows unlicensed school staff to administer emergency anti-seizure medication to students with acute, prolonged or repetitive seizure 2. Licensed healthcare provider and parent authorizations for medication must be completed and signed. Healthcare Provider Authorization must specify student specific seizure symptoms, including frequency, type, duration, medication dosage, potential side effects and instructions when to call the paramedics. 3. Diastat training must be student specific- demonstration. Verbalization of the following by the trainee will occur upon completion of the training: a. Identification of characteristics of student’s seizures b. Understanding of Diastat order from the licensed healthcare provider c. Location, storage and disposal of Diastat d. Appropriate steps of administration of Diastat e. Care of the student before, during and after the administration of Diastat f. Documentation of Diastat administration 4. Parent/guardian must notify the school if Diastat was administered within the past 4 hours on a school day. C. PERSONNEL 1. School nurse or school physician 2. Designated school personnel who possess current First Aid and CPR Certification and are trained by the school nurse or the school physician.
    [Show full text]
  • Over-The-Counter (OTC) Medications and Products 2021 Beneit Catalog and Order Form
    Keep this catalog for future orders. Over-the-Counter (OTC) Medications and Products 2021 Beneit Catalog and Order Form Get OTC items delivered to your doorstep at no additional cost! NationsOTC.com Save Money with Your OTC Beneit Your OTC beneit allows you to purchase medications, health and wellness items, and irst aid supplies with home delivery at no additional cost. Ordering OTC Products is Simple 1 Choose Your Ordering Method Select the option that is best for you: ONLINE Visit NationsOTC.com and place an order. PHONE Call 833-SHOP-OTC (833-746-7682) TTY: 711 and speak with a Member Experience Advisor Monday-Friday, 8:00 a.m.-8:00 p.m. ET. Language support services are available, if needed. MAIL Complete the order form included in this catalog and mail to NationsOTC. 2 Select Your Products Choose products sorted by category. 3 Place Your Order Receive your delivery within 2-5 business days after your order is processed. If you have any questions or need help placing your order, we’re here for you. Member Experience Advisors are available at 833-SHOP-OTC (833-746-7682) TTY: 711 to make sure you get the items you need. 2 Keep this catalog to reference for future orders. Helpful Information Your Beneit Coverage Beneit Usage: This beneit is intended for members only. CMS does not allow this beneit to be used for your family or friends. Disenrollment: If you disenroll from your health plan, your OTC beneit will automatically end. _______________________________________________________________________________ Ordering Your OTC Products Products: Available over-the-counter items include health and wellness products that do not require a prescription.
    [Show full text]
  • PEG Base S.A
    Formulation Record Name: Progesterone Suppositories Strength: 200 mg Dosage Form: Suppository Route of Administration: Vaginal Date of Last Review or Revision: Today Person Completing Last Review or Revision: RPS Formula: Ingredient Quantity Physical Description Solubility Therapeutic Activity progesterone 200 mg/supp white, crystalline powder insoluble in water; soluble hormone replacement in alcohol silica gel 35.0 mg/supp white, amorphous powder insoluble in water; soluble suspending agent in hot alkaline hydroxides PEG Base s.a. Water miscible semisolid suppository base Example Calculations: Weight of suppository with only PEG Base = 2.1 gm Weight of progesterone in each suppository = 0.2 gm Density Factor of progesterone in PEG Base = 0.92 For making 10 suppositories (calculations based on 12 for anticipated loss of material): Weight of progesterone needed = 0.2 g × 12 = 2.4 g Weight of PEG needed if plain suppository = 2.1 g × 12 = 25.2 g Weight of PEG displaced: (weight of progesterone)/(density factor) = 2.4 g/0.92 = 2.6 g Weight of PEG base to weigh = 25.2 g - 2.6 g = 22.6 g Weight of Silica Gel to weigh = 35 mg × 12 = 420 mg (Note: displacement by silica gel is ignored) PEG base is 40% PEG 300 and 60% PEG 3350. Density of PEG 300 = 1.13. Weight of PEG base to weigh = 22.6 g Weight of PEG 300: 22.6 g × 0.4 = 9.0 g or 8.0 ml Weight of PEG 3350: 22.6 g × 0.6 = 13.6 g The shaded lines will need to be calculated based on the suppository weight in the individual molds.
    [Show full text]
  • Intramuscular and Rectal Therapies of Acute Seizures
    Epilepsy & Behavior 49 (2015) 307–312 Contents lists available at ScienceDirect Epilepsy & Behavior journal homepage: www.elsevier.com/locate/yebeh Review Intramuscular and rectal therapies of acute seizures Ilo E. Leppik a,b,c,⁎,SimaI.Patelb,c a Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA b MINCEP Epilepsy Care, University of Minnesota Physicians, Minneapolis, MN, USA c Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA article info abstract Article history: The intramuscular (IM) and rectal routes are alternative routes of delivery for antiepileptic drugs (AEDs) Accepted 1 May 2015 when the intravenous route is not practical or possible. For treatment of acute seizures, the AED used should Available online 11 June 2015 have a short time to maximum concentration (Tmax). Some AEDs have preparations that may be given intramus- cularly. These include the benzodiazepines (diazepam, lorazepam, and midazolam) and others (fosphenytoin, le- Keywords: vetiracetam). Although phenytoin and valproate have parenteral preparations, these should not be given Intramuscular intramuscularly. A recent study of prehospital treatment of status epilepticus evaluated a midazolam (MDZ) Rectal Acute seizures autoinjector delivering IM drug compared to IV lorazepam (LZP). Seizures were absent on arrival to the emergen- Antiepileptic drugs cy department in 73.4% of the IM MDZ compared to a 63.4% response in LZP-treated subjects (p b 0.001 for supe- riority). Almost all AEDs have been evaluated for rectal administration as solutions, gels, and suppositories. In a placebo-controlled study, diazepam (DZP) was administered at home by caregivers in doses that ranged from 0.2 to 0.5 mg/kg.
    [Show full text]
  • 2021 Formulary Annual Notice of Change
    Updated: January 1, 2021 2021 Formulary Annual Notice of Change Commercial 3-Tier Plans This is a listing of the changes that have occurred to the 2021 Commercial 3-Tier formulary. For a complete list, please refer to our website and review the 2021 Commercial Comprehensive Formulary (Drug List). Please carefully review these changes. If you have any questions or need to obtain updated coverage determination and exception information, please call Customer Service toll-free at 1.855.443.4735 (TTY/TDD relay: 1.800.955.8771) Monday through Friday from 8 a.m. to 6 p.m. or visit myHFHP.org. This information is not a complete description of benefits. Contact the plan for more information. Limitations, copayments, and restrictions may apply. Benefits and copayments/co-insurance may change on January 1 of each year. You must generally use network pharmacies to use your prescription drug benefit. The Formulary and pharmacy network may change at any time. You will receive notice when necessary. Health First Commercial Plans, Inc. is doing business under the name of Health First Health Plans. Health First Health Plans does not discriminate on the basis of race, color, national origin, disability, age, sex, gender identity, sexual orientation, or health status in the administration of the plan, including enrollment and benefit determinations. 36194_MPINFO8809(10/2020) Effective Date:1/1/2021 Medication Name Change Description AIMOVIG AUTOINJECTOR 140 MG/ML Formulary Addition SUBCUTANEOUS AUTO-INJECTOR AIMOVIG AUTOINJECTOR 70 MG/ML Formulary Addition
    [Show full text]